Effects of chemerin/CMKLR1 in obesity-induced hypertension and potential mechanism.
暂无分享,去创建一个
C. Weng | Kan Yang | Hong Yuan | Weihong Jiang | Jiangang Wang | Li-ping Peng | Xiao-bo Li | Zhijie Shen | Chunyan Weng
[1] G. Aksan,et al. Chemerin as an independent predictor of cardiovascular event risk , 2016, Therapeutic advances in endocrinology and metabolism.
[2] R. Mattes,et al. Higher plasma lipopolysaccharide concentrations are associated with less favorable phenotype in overweight/obese men , 2015, European Journal of Nutrition.
[3] S. Watts,et al. Chemerin: A comprehensive review elucidating the need for cardiovascular research. , 2015, Pharmacological research.
[4] R. Touyz,et al. Chemerin Regulates Crosstalk Between Adipocytes and Vascular Cells Through Nox , 2015, Hypertension.
[5] E. Reisin,et al. Treatment: special conditions. Metabolic syndrome: obesity and the hypertension connection. , 2015, Journal of the American Society of Hypertension : JASH.
[6] K. Neves,et al. Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity? , 2014, Clinical science.
[7] A. Dorrance,et al. Chemerin Connects Fat to Arterial Contraction , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[8] Z. Fortes,et al. The adipokine chemerin augments vascular reactivity to contractile stimuli via activation of the MEK-ERK1/2 pathway. , 2012, Life sciences.
[9] Geoffrey A Head,et al. Developmental origins of obesity‐related hypertension , 2012, Clinical and experimental pharmacology & physiology.
[10] K. Ahn,et al. Chemerin and Adiponectin Contribute Reciprocally to Metabolic Syndrome , 2012, PloS one.
[11] Weiqing Wang,et al. The association of serum chemerin level with risk of coronary artery disease in Chinese adults , 2012, Endocrine.
[12] W. Spiering,et al. Mechanisms linking obesity to hypertension , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[13] T. Kotchen. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. , 2010, American journal of hypertension.
[14] A. Saremi,et al. Twelve-Week Aerobic Training Decreases Chemerin Level and Improves Cardiometabolic Risk Factors in Overweight and Obese Men , 2010, Asian journal of sports medicine.
[15] D. Goff,et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.
[16] P. Zimmet,et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. , 2007, Endocrinology.
[17] E. Butcher,et al. Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism* , 2007, Journal of Biological Chemistry.
[18] A. Somlyo,et al. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. , 2003, Physiological reviews.
[19] R. Paul,et al. Distinct Pathways of Ca 2+ Sensitization in Porcine Coronary Artery: Effects of Rho-Related Kinase and Protein Kinase C Inhibition on Force and Intracellular Ca 2+ , 2001, Circulation research.
[20] P. Gallagher,et al. Rho-kinase-mediated Ca2+-independent contraction in rat embryo fibroblasts. , 2004, American journal of physiology. Cell physiology.